ArticleJournal of cancer research and clinical oncology2023

The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study.

Deniz Can Guven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.